The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Buzy Peter L since year 2005.
The trader's CIK number is 1252570.
At the time of the last reporting, Buzy Peter L was the President, Gene Therapy of Catalent, Inc. .
(stock ticker symbol CTLT).
See this page for all insider trading activities at Catalent, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2010-03-19||MATK||Martek Biosciences Corp||Option Ex||7,305||.00||0|
|2010-03-09||MATK||Martek Biosciences Corp||Option Ex||16,000||12.00||192,000|
|2009-03-19||MATK||Martek Biosciences Corp||Option Ex||4,795||.00||0|
|2008-03-19||MATK||Martek Biosciences Corp||Option Ex||2,788||.00||0|
|2007-12-18||MATK||Martek Biosciences Corp||Sale||40,000||28.12||1,124,880|
|2007-12-18||MATK||Martek Biosciences Corp||Option Ex||50,000||15.50||775,000|
|2007-04-04||MATK||Martek Biosciences Corp||Buy||3,864||21.22||81,994|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Buzy Peter L (President, Gene Therapy of Catalent, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.